I order to study the time-course of myeloperoxidase (MPO) and eosinophil cationic protein (ECP) as parameters for monitoring inflammation in cystic fibrosis (CF), we investigated ten patients during both a 14-day intravenous antibiotic treatment and a corresponding self control. Modified Shwachman-Kulczycki score improved significantly (p < 0.008), C-reactive protein (CRP) levels decreased significantly (p < 0.05) during antibiotic treatment, while in the control phase there were no significant differences. Lung function parameters did not change significantly during antibiotic treatment or control phase. Serum Pulmonary function tests were performed in a whole-body plethysmograph (E. Jaeger, Wrzburg, Germany). A sweat test was Fig. 3A ). In the control phase, no changes in serum ECP could be noted: 13.8g/1 on day 1, 12.21.tg/1 on day 5, and 13.6 I.tg/1 on day 12 (Table 3, Fig. 3A) . Peripheral blood eosinophil counts increased during antibiotic treatment (p < 0.03) but not during the control phase (Table 3 , Fig. 3B ).
Sputum data: Microbial growth of Pseudomonas aeruginosa in sputum did not show a significant decrease both during the antibiotic treatment and the control phase (Table 3 ). In general, sputum concentrations of MPO and ECP were 500-to 1 000-fold higher than in serum (Table  4 ). There was no statistically significant correlation between serum and sputum MPO or between serum and sputum ECP concentration. 
Discussion
Originally, a placebo-controlled design was intended and the present study was started in this manner. However, after two patients suffered from pulmonary exacerbations during a placebo 'treatment', the study was continued as an intraindividual cross-over design (each patient serving as its own control). Conditions during the antibiotic treatment were completely comparable (e.g., in terms of physiotherapy, inhalation therapy, dietetic intervention) with those during the control phase, with the exception of the intravenous treatment.
The reason for choosing a control-phase in addition to antibiotic treatment was the possible bias of the admission to hospital, which may improve a patient's well-being by intensified basic therapy. In order to minimize observer bias, the investigator of the study was not the physician responsible for the care of the patients on the ward.
In order to study the monitoring character of the parameters investigated, blood was sampled 
